Breaking News
Sort by:
Date
Top Post
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Asher Bio Closes $108 Million Series B Financing
Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today […]
- Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC) Read more
- AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors Read more
- Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia Read more
- Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer Read more
- NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition Read more